BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for the Sudeep Pharma Limited IPO: Step-by-Step Investment Guide

 

Sudeep Pharma Limited operates in the pharmaceutical excipients, food-grade minerals, and speciality nutrition ingredients segment. The company’s portfolio spans various mineral-based products that meet the requirements of the pharmaceutical, food, and nutrition industries. Its operations are supported by research-led capabilities and compliant manufacturing processes, which enable it to serve a diverse set of customers across several global markets. With multiple product categories, including pharmaceutical and nutrition solutions, speciality ingredients, and triturates, the company maintains a stable presence within its sector.

To apply for the Sudeep Pharma IPO, an investor can log in to an investment or trading platform that offers IPO application services and locate the IPO within the platform’s IPO section. After selecting the issue, the investor can fill out the application form, select the quantity as per the applicable lot size, and complete the payment process via an available method, such as UPI, which blocks the required amount. Once the details are submitted, the investor can monitor the platform for updates on the application status.

For more details, visit the Sudeep Pharma Limited IPO page.

Sudeep Pharma Limited IPO Details and Objectives

Details

Information

IPO Date

November 21, 2025 to November 25, 2025

Issue Size

1,50,92,750 shares (aggregating up to ₹895.00 Cr)

Price Band

₹563 to ₹593 per share

Lot Size

25 shares

Listing At

BSE NSE

Purpose of the IPO

  • Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility

  • General Corporate Purpose

Timeline of Sudeep Pharma Limited IPO

Event

Date

IPO Open Date

Fri, Nov 21, 2025

IPO Close Date

Tue, Nov 25, 2025

Tentative Allotment

Wed, Nov 26, 2025

Initiation of Refunds

Thu, Nov 27, 2025

Credit of Shares to Demat

Thu, Nov 27, 2025

Tentative Listing Date

Fri, Nov 28, 2025

Cut-off time for UPI mandate confirmation

5 PM on Tue, Nov 25, 2025

Pricing & Lot Size of Sudeep Pharma Limited IPO

Price Band for the IPO

  •  ₹563 to ₹593 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Retail (Min)

1

25

₹14,825

Retail (Max)

13

325

₹1,92,725

S-HNI (Min)

14

350

₹2,07,550

S-HNI (Max)

67

1,675

₹9,93,275

B-HNI (Min)

68

1,700

₹10,08,100

Sudeep Pharma Limited IPO Application Process

The Sudeep Pharma Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using the broker's app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate Sudeep Pharma Limited IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (minimum lot size: 25 shares) within the price band of ₹563 to ₹593 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹420.11 crore in FY24 to ₹922.26 crore as of June 2025.

  • Total income: Reached ₹130.08 crore in FY25.

  • Profit After Tax (PAT): Stood at ₹31.27 crore for June 2025.

  • Net Worth: Recorded at ₹688.32 crore in FY25.

  • Reserves and Surplus: Recorded at ₹668.52 crore (June 2025), growing steadily over the years.

  • EBITDA: Stood at ₹48.57 crore in June 2025.

Recent Performance and Growth Prospects

  • The company has shown consistent expansion in its asset base, reflecting the scale of its ongoing operations and investments.

  • Its income level has displayed steady progress, supported by business activities across its operating segments.

  • Profitability has remained stable, indicating sustained performance during the recent period.

  • The organisation’s financial position appears supported by an increasing net worth, demonstrating internal strengthening over time.

  • Reserves have continued to grow, suggesting careful financial management and retained earnings.

  • Operating efficiency has been reinforced by stable operational profits, contributing to the company’s overall financial outlook.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company operates in a sector influenced by regulatory requirements, and any changes in compliance guidelines may affect its operations.

  • Dependence on raw materials and market-driven demand conditions may introduce uncertainties that could influence future performance.

Opportunities and Growth Potential

  • The company’s diversified portfolio across pharmaceutical, food, and nutrition segments creates scope for expansion within multiple markets.

  • Its research-driven approach and compliant manufacturing facilities may support ongoing development of new products and operational strengthening.

Key Performance Indicator (KPI)

KPI

Values

Debt/Equity

0.20

RoNW

27.88%

PAT Margin

27.63%

EBITDA Margin

39.70%

Price to Book Value

12.93

Market Capitalization

₹6,697.85 Cr.

Sudeep Pharma Limited IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

MUFG Intime India Pvt.Ltd.

ICICI Securities Ltd.

Company Address of Sudeep Pharma Limited Ltd.

Sudeep Pharma Ltd. 129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340

Phone: +91 265 284 0656

Email: cs.sudeep@sudeepgroup.com

Website: https://www.sudeeppharma.com/

Conclusion

Sudeep Pharma Limited’s IPO offers information about the company’s operations, financial position, and business activities across the pharmaceutical excipients and mineral-based ingredients segment. The details shared in the issue documents outline its focus areas, manufacturing capabilities, and presence across domestic and global markets. Investors can review these aspects to understand the organisation’s background and key functions before proceeding further.

The application process is structured to guide investors through each step, from accessing the IPO section to confirming the payment mandate. By following the instructions provided through their respective trading platforms, applicants can complete the procedure and track subsequent updates. This approach allows investors to assess the IPO based on the available disclosures and timelines.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Sudeep Pharma IPO allotment status.

Published Date : 19 Nov 2025

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.6 App Rating

icon-with-text

4 Languages

icon-with-text

₹6,800+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|